Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ICU
- Price
- 0.35
- Stock movement up
- +0.00 (0.04%)
- Company name
- LMF Acquisition Opportunities Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 22.33M
- Ent value
- 26.89M
- Price/Sales
- 328.41
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -87.30%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-09-12
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
ICU does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 328.41 |
| Price to Book | - |
| EV to Sales | 395.41 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 27.91M |
| EPS (TTM) | -7.41 |
| FCF per share (TTM) | -4.11 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 68.00K |
| Gross profit (TTM) | 68.00K |
| Operating income (TTM) | -16.02M |
| Net income (TTM) | -30.29M |
| EPS (TTM) | -7.41 |
| EPS (1y forward) | -0.46 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 100.00% |
| Operating margin (TTM) | -23555.88% |
| Profit margin (TTM) | -44538.24% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 2.08M |
| Net receivables | 68.00K |
| Total current assets | 3.62M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 4.59M |
| Accounts payable | 3.69M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 6.64M |
| Total liabilities | 6.64M |
| Shareholder's equity | -2.05M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -15.80M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -16.80M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -660.40% |
| Return on Invested Capital | 1475.93% |
| Cash Return on Invested Capital | 818.52% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.81 |
| Daily high | 0.81 |
| Daily low | 0.78 |
| Daily Volume | 486K |
| All-time high | 308.75 |
| 1y analyst estimate | 2.00 |
| Beta | -1.02 |
| EPS (TTM) | -7.41 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ICU | S&P500 | |
| Current price drop from All-time high | -99.74% | -1.46% |
| Highest price drop | -99.93% | -56.47% |
| Date of highest drop | 6 Jun 2024 | 9 Mar 2009 |
| Avg drop from high | -91.60% | -10.99% |
| Avg time to new high | 142 days | 12 days |
| Max time to new high | 705 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
22.33M
Marketcap category
Small-cap
Description
SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
Employees
19
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page